Skip to main content
. Author manuscript; available in PMC: 2013 Dec 1.
Published in final edited form as: Clin Pharmacol Ther. 2012 Nov 14;92(6):771–777. doi: 10.1038/clpt.2012.186

Table 2.

Regression analyses of the predictors of the hydroxybupropion/bupropion ratio, hydroxybupropion levels, and bupropion levels.

Predictors OH-BUP/BUP ratio
R2=0.055 P=0.02
OH-BUP levels (ng/ml)
R2=0.11 P=0.001
BUP levels (ng/ml)
R2=0.03 P=0.21
B β 95% CI P B β 95% CI P B β 95% CI P
Bupropion adherent only (n=154)
CYP2B6 groups (Intermediate vs. normal) −16.9 −0.20 −31.8 to −1.9 0.027 −162.3 −0.17 −325.8 to 1.3 0.052 13.5 0.17 −0.3 to 27.4 0.056
CYP2B6 groups (Slow vs. normal) −24.3 −0.23 −42.7 to −6.0 0.010 −333.6 −0.28 −534.3 to −132.9 0.001 9.0 0.09 −8.0 to 26.0 0.297
Age (Increasing) 0.2 0.04 −0.4 to 0.8 0.580 9.1 0.22 2.7 to 15.6 0.006 0.2 0.07 −0.3 to 0.8 0.366

B is the unstandardized coefficient. β is the standardized coefficient (i.e. standardized to a variance of 1). The B and β provided refers to the variables listed in parentheses beside each categorical predictor. OH-BUP=hydroxybupropion. Total n=154 (slow: n=31, intermediate: n=64, normal: n=58).